Clinical Trials on SARS-CoV-2 Infection (COVID-19)

Total 8132 results

Sinocelltech Ltd.

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

COVID-19 | SARS-CoV-2 Infection
Health Institutes of Turkey

Completed

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

COVID-19 | Sars-CoV-2 Infection

Turkey
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Medicago
Mitsubishi Tanabe Pharma Corporation

Terminated

Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19）

SARS-CoV-2 Infection

Japan
Zhejiang ACEA Pharmaceutical Co. Ltd.

Completed

Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients

SARS-CoV-2 Infection

China
Novavax

Completed

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.

COVID-19 | SARS-CoV-2 Infection

United States, Brazil, South Africa, Germany, Canada, Israel
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Active, not recruiting

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

SARS-CoV-2 Infection

China
University of Chicago
Rush University Medical Center

Active, not recruiting

Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19

SARS-CoV-2 Infection

United States
Shanghai Zerun Biotechnology Co.,Ltd

Active, not recruiting

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

COVID-19 | SARS-CoV-2 Infection

Mali
Novavax

Completed

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

COVID-19 | SARS-CoV-2 Infection

United Kingdom
BioNTech SE
Pfizer

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults

COVID-19 | SARS-CoV-2 Infection

Japan
BioNTech SE
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

COVID-19 | SARS-CoV-2 Infection

United States
BioNTech SE
Pfizer

Completed

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

COVID-19 | SARS-CoV-2 Infection

United States
P & B Group
MediAxe CRO

Terminated

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

SARS-CoV-2 Infection

France
Memo Therapeutics AG

Completed

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

SARS-CoV-2 Infection

Australia
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

SARS-CoV-2 Infection

China
University of Pecs
Hungarian Ministry of Innovation and Technology; HECRIN Consortium

Completed

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

SARS-CoV-2 Infection

Hungary
Medicago

Active, not recruiting

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

SARS-CoV-2 Infection

United States, Canada, United Kingdom, Argentina, Brazil, Mexico
Eshmoun Clinical Research Center

Completed

I VACCIN Hospitalization of COVID-19 Patients

COVID-19 | SARS CoV 2 Infection

Tunisia
Celltrion

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

SARS-CoV-2 Infection

Korea, Republic of
Dentaid SL
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. (CPC COVID)

SARS-CoV-2 Infection

Spain
Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

COVID-19

Argentina
Hospital Italiano de Buenos Aires

Completed

Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia (PLASM-AR)

COVID-19 | SARS-CoV-2 | SARS Virus

Argentina
AstraZeneca

Not yet recruiting

eVusheld Assessment reaL wORld Effectiveness in DoD Health System (VALOR DoD)

COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease
Jessa Hospital

Terminated

Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR

Covid-19 | SARS-CoV-2 | Diagnosis | Polymerase Chain Reaction

Belgium
University Hospital, Limoges

Withdrawn

Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection (PRODEX)

Respiratory Failure | COVID-19 Infection | Sars-cov-2 | Palliative Situation

France
Instituto de Investigación Hospital Universitario...

Completed

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. (MeCOVID)

Coronavirus Infection | SARS-CoV 2 | Covid19

Spain
Assistance Publique - Hôpitaux de Paris

Unknown

Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort. (CORIMUNO-NIVO)

COVID19- Infection With SARS-CoV-2 Virus

France
Yu Qin

Active, not recruiting

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Prevention of COVID-19 Caused by SARS-CoV-2

China
Fundación Huésped
Ministerio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...

Recruiting

Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts (PENTZ)

Covid19 | SARS-CoV-2 Infection | Households Contacts

Argentina
East Suffolk and North Essex NHS Foundation Trust
University of Suffolk

Completed

COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI)

COVID-19 | SARS-CoV 2 | COVID

United Kingdom
Lizora LLC
Sheng'ai Traditional Chinese Medicine Hospital

Completed

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

COVID-19 | Influenza | Post-COVID-19 Syndrome

China
60P Australia Pty Ltd

Not yet recruiting

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Infectious Disease | SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 | COVID 19 Disease | Mild to Moderate COVID 19 Disease
ProgenaBiome

Completed

A Retrospective Study of COVID-19 Treatments

Covid19 | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection | COVID-19 Acute Respiratory Distress Syndrome | COVID-19 Acute Bronchitis | COVID-19 Lower Respiratory Infection

United States
Hospices Civils de Lyon

Unknown

Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19

the Prognostic Value of Ferritin | Glycosylated Ferritin in SARS-CoV-2 Infection in Hospitalized COVID-19 Patients

France
Bangkok Metropolitan Administration Medical College...

Completed

SARS-COV-2 Detection From Used Surgical Mask

SARS-CoV-2 Virus

Thailand
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Understanding the Long-term Impact of COVID on Children and Families

SARS-CoV-2 Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Surveillance of Individuals Following SARS-CoV-2 Infection

COVID-19

United States
Elsan

Completed

Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients (COVELEC)

SARS-CoV 2 | Hospitalisation-Associated Infection

France
Valneva Austria GmbH
National Institute for Health Research, United Kingdom

Completed

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

SARS-CoV-2 Virus Infection

United Kingdom
Schön Klinik Berchtesgadener Land

Completed

Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection

Post-COVID19

Germany
National Polytechnic Institute, Mexico

Unknown

Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T) (FUTURE-T)

COVID-19 | SARS-CoV-2 Infection

Mexico
Gamaleya Research Institute of Epidemiology and...

Not yet recruiting

Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray (SPRAY)

COVID-19 | SARS-CoV-2 Acute Respiratory Disease
Centre Hospitalier Intercommunal Robert Ballanger
Groupe Hospitalier Pitie-Salpetriere

Unknown

Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est

SARS-CoV 2 | COVID

France
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health; National Institutes of Health...

Recruiting

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

SARS-CoV-2 Infection

United States
San Diego State University
Family Health Centers of San Diego

Recruiting

Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos

SARS-CoV-2 Infection

United States
Indonesia University

Recruiting

COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients (SURVIVOR)

COVID-19 | SARS CoV-2 Infection

Indonesia
Ruijin Hospital

Recruiting

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

Covid19 | SARS-CoV-2 Infection

China
St. Jude Children's Research Hospital
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Active, not recruiting

St. Jude Tracking of Viral and Host Factors Associated With COVID-19

COVID-19 | Coronavirus Infection | SARS-CoV-2 | Coronavirus

United States

Clinical Trials on SARS-CoV-2 Infection (COVID-19)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations